---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-25-003305"
form_type: "8-K"
ticker: "DRMA"
cik: "0001853816"
company_name: "Dermata Therapeutics, Inc."
filed_at: "2025-03-25T23:59:59+00:00"
generated_at: "2026-05-24T06:03:48.187247+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Dermata Therapeutics receives Nasdaq delisting notice for failing minimum stockholders' equity

## Summary
- Nasdaq notified Dermata on March 25, 2025, of non-compliance with $2.5M minimum stockholders' equity rule.
- Company reported stockholders' equity of $1.6M as of Dec 31, 2024, below required threshold.
- Dermata has 45 days, until May 9, 2025, to submit a plan; possible extension to Sept 21, 2025.
- Securities continue trading on Nasdaq while company evaluates options to regain compliance.
- If plan rejected or compliance not regained, delisting proceedings may commence; hearing available.

## SEC filing metadata
- accession: 0001654954-25-003305
- form_type: 8-K
- ticker: DRMA
- cik: 0001853816
- company_name: Dermata Therapeutics, Inc.
- filed_at: 2025-03-25T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853816/000165495425003305/0001654954-25-003305-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853816/000165495425003305/drma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-25-003305
- JSON: https://secwatch.observer/filing/0001654954-25-003305.json
- Plain text: https://secwatch.observer/filing/0001654954-25-003305.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.